Podnos Yale sold TOI

June 8, 2026 · Form 4 insider transaction

Podnos Yale sold 23,451 shares of Starling Oncology Inc at $5.38 per share, a transaction worth $126.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
23,451
Price
$5.38
Total value
$126.1K
Role
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 8, 2026
Filing dateJune 9, 2026
Shares owned after259,527
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

Price is the volume weighted average selling price of all sales on behalf of the Reporting Person on June 8, 2028 within a one-dollar range. Actual prices ranged from $5.35 to $5.42. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.; Sales were made on behalf of the Reporting Person pursuant to the Rule 10b5-1(c) plan that was adopted on 08/26/2025.

View the original Form 4 on SEC EDGAR